Professor, Hematology and Medical Oncology, Emory University School of Medicine
Hematology
Dr. Otis W. Brawley Jr., MD
|
|
Give Review
Otis Brawley is an expert in the field of Hematology. He went to medical school at University of Chicago Pritzker School of Medicine. University of Chicago Pritzker School of Medicine has a rank of 10 in research and a 19 in primary care He received awards:"Fellow (FASCO)" and "Whos Who in Medicine and Healthcare". Otis Brawley has written publications. He has 95 publications published with PubMed. The lastest publication is: 'Minority inclusion in clinical trials issues and potential strategies.'
Publications
- Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations.
- The Meaning of Race in Prostate Cancer Treatment.
- Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society.
- Breast Cancer screening: Time for rational discourse.
- Screening mammography: do the benefits always outweigh the harms?
- Delivering High-Quality and Affordable Care Throughout the Cancer Care Continuum.
- Health disparities in breast Cancer.
- Accelerating progress on non-communicable diseases.
- Health care policy and Cancer survivorship.
- Examining racial differences in diffuse large B-cell lymphoma presentation and survival.
- Obesity-driven inflammation and Cancer risk: role of myeloid derived suppressor cells and alternately activated macrophages.
- A brief history of the American Cancer Society Extramural Research Program.
- Trends in Prostate cancer in the United States.
- Disparities in the Early Adoption of Chemoimmunotherapy for Diffuse Large B-cell Lymphoma in the United States.
- International variation in Prostate cancer incidence and mortality rates.
- Prostate Cancer Screening: What We Know, Don't Know, and Believe.
- Cancer screening in the United States, 2012: A review of current American Cancer Society guidelines and current issues in Cancer screening.
- Reviewer Acknowledgment 2011.
- Palliative Care and the Quality of Life.
- Avoidable Cancer deaths globally.
- Peak window of suicides occurs within the first month of diagnosis: implications for clinical oncology.
- The american Cancer society and the american health care system.
- Cancer screening in the United States, 2011: A review of current American Cancer Society guidelines and issues in Cancer screening.
- Toward a better understanding of race and Cancer.
- Sixty years of CA: a Cancer journal for clinicians.
- From the guest editors: introduction for the impact of health care reform on Cancer patients.
- Extensive inguinal lymphadenectomy improves overall 5-year survival in penile Cancer patients: results from the Surveillance, Epidemiology, and End Results program.
- Introducing the 2010 American Cancer Society Prostate cancer screening guideline.
- Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in Cancer screening.
- A black-white comparison of the quality of stage-specific colon Cancer treatment.
- The globalization of tobacco use: 21 challenges for the 21st century.
- Disparities in medical care among commercially insured patients with newly diagnosed breast Cancer: opportunities for intervention.
- From the editors.
- Information over exaggeration.
- Prostate cancer screening; is this a teachable moment?
- Oropharyngeal Cancer, race, and the human papillomavirus.
- Taking action to ease suffering: advancing Cancer pain control as a health care priority.
- Is race really a negative prognostic factor for Cancer?
- Characteristics and treatment modalities for African American women diagnosed with stage III breast Cancer.
- Prostate cancer: current evidence weighs against population screening.
- American society of clinical oncology policy statement: disparities in Cancer care.
- Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in Cancer screening.
- Cancer and disparities in health: perspectives on health statistics and research questions.
- New ACS chief medical officer. Interview by Carrie Printz.
- Effects of an outreach and internal navigation program on breast Cancer diagnosis in an urban Cancer center with a large African-American population.
- High prevalence of triple-negative tumors in an urban Cancer center.
- Age and grade trends in Prostate cancer (1974-2003): a Surveillance, Epidemiology, and End Results Registry analysis.
- National Institutes of Health Consensus Development Conference statement: hydroxyurea treatment for sickle cell disease.
- Cancer screening in the United States, 2008: a review of current American Cancer Society guidelines and Cancer screening issues.
- NIH consensus development statement on hydroxyurea treatment for sickle cell disease.
- Prostate cancer and race.
- Racial disparities in lung Cancer.
- Racial differences in the incidence and outcomes for patients with hematological Malignancies.
- Racial disparities in colorectal Cancer.
- Race and disparities in health.
- Are racial and ethnic minorities less willing to participate in health research?
- Lung Cancer and race: equal treatment yields equal outcome among equal patients, but there is no equal treatment.
- Effects of untreated syphilis in the negro male, 1932 to 1972: a closure comes to the Tuskegee study, 2004.
- Cancer screening in theory and in practice.
- Prostate cancer screening: clinical applications and challenges.
- The study of accrual to clinical trials: can we learn from studying who enters our studies?
- Nonmedical factors in treatment selection.
- Myeloma and race: a review of the literature.
- Prostate cancer in black and white Americans.
- Colorectal carcinoma in black and white race.
- Population categorization and Cancer statistics.
- Introduction: Cancer and health disparities.
- Hormonal prevention of Prostate cancer.
- Informed consent for Prostate-specific antigen-based screening.
- Some perspective on black-white Cancer statistics.
- Oophorectomy in carriers of BRCA mutations.
- Survival of blacks and whites after a Cancer diagnosis.
- Disaggregating the effects of race and poverty on breast Cancer outcomes.
- The potential for Prostate cancer chemoprevention.
- Cancer screening in the United States, 2013: a review of current American Cancer Society guidelines, current issues in Cancer screening, and new guidance on cervical c...
- The effect of dutasteride on the usefulness of Prostate specific antigen for the diagnosis of high grade and clinically relevant Prostate cancer in men with a previous...
- Race and triple negative threats to breast Cancer survival: a population-based study in Atlanta, GA.
- The worldwide epidemiology of Prostate cancer: perspectives from autopsy studies.
- Effect of dutasteride on the risk of Prostate cancer.
- Curbing tobacco''s toll starts with the professionals: World No Tobacco Day.
- Estrogen receptor breast Cancer phenotypes in the Surveillance, Epidemiology, and End Results database.
- The future of Prostate cancer prevention.
- The epidemiology of Prostate cancer in the United States.
- Frequency distributions of breast Cancer characteristics classified by estrogen receptor and progesterone receptor status for eight racial/ethnic groups.
- Potential agents for Prostate cancer chemoprevention.
- After a treatment breakthrough: a comparison of trial and population-based data for advanced testicular Cancer.
- Design of the Prostate Cancer Prevention Trial (PCPT).
- Are mass Cancer screenings effective?
- A randomized pilot study of alternating or simultaneous zidovudine and didanosine therapy in patients with symptomatic human immunodeficiency virus infection.
- The potential for hormonal prevention trials.
- 5-Alpha-reductase inhibition and Prostate cancer prevention.
- Vasectomy and increased risk of Prostate cancer.
- Re: Chemoprevention studies in the community clinical oncology program.
- Minority inclusion in clinical trials issues and potential strategies.
Schools
U Of Chgo Div Of Bio Sci Pritzker Sch Of Med
University HospsCase West Res
Nci
Conditions Treated
- Prostate Cancer
- Secondary Malignancies
Doctors Specialties
- Medical Oncology
- Oncology
- Hematology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- Blue Choice HMO
- Blue Choice Option POS
- Blue Open Access POS
- Cigna HMO
- Cigna PPO
- First Health (Coventry Health Care) PPO
- Choice Care PPO
- Preferred PPO
- Medicaid
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- Fellow (FASCO)
- Whos Who in Medicine and Healthcare
Education
-
Case Western Reserve University - University Hospitals -
University of Chicago Pritzker School of Medicine
Hospital
-
Emory University Hospital -
Emory University Hospital Midtown -
Grady Memorial Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Wayne B. Harris, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Douglas C. Collins, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Angelica G. James-Herry, MD |
|
|
Dr. Natalyn Hawk, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Salahattin M. Sanal, MD |
|
|
Dr. Margaret K. Offermann, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James S. Kim, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Pamela B. Brill, CPNP |
|
Dr. Shawn M. Jobe, MD
This Doctor is OpenDoctor Recommended.
|